Intercept Pharmaceuticals (NASDAQ:ICPT) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on ICPT. Canaccord Genuity Group reiterated a hold rating and issued a $19.00 price objective (down from […]
More Stories
Amazon Cuts 16,000 Jobs in Latest Restructuring Push
By Tom Ozimek Amazon said on Jan. 28 it will eliminate about 16,000 roles across the company as part of...
Federal Reserve Leaves Interest Rates Unchanged in First Policy Decision of 2026
By Andrew Moran The Federal Reserve hit the brakes on its easing cycle and left interest rates unchanged in the...
Thousands Rally in Calgary’s Stampede Park in Support of Alberta Separation
By Olivia Gomm Thousands of people attended a rally in Calgary’s Stampede Park this week in support of Alberta separation,...
10 Best Google Chrome Extensions Must-Have on Your Desktop
Frustrated with continuous switching between tabs? Don’t worry, you are not alone. After working for more than 8 years as...
Trump Touts Upcoming Launch of ‘Trump Accounts’
By Emel Akan WASHINGTON—The Treasury Department is hosting a full-day summit on Wednesday to mark the launch of Trump Accounts,...
Trump Says John Deere Will Invest $70 Million to Build Excavator Factory in North Carolina
By Aldgra Fredly President Donald Trump announced on Jan. 27 that farm equipment maker John Deere will invest $70 million...